CN Patent

CN114306261A — 巴洛沙韦酯片及其制备方法

Assigned to Aomei Pharmaceutical Hainan Co ltd · Expires 2022-04-12 · 4y expired

What this patent protects

本申请涉及于药物制剂技术领域，尤其涉及一种巴洛沙韦酯片及其制备方法，提供了一种巴洛沙韦酯片，其组成为巴洛沙韦酯、包合剂、填充剂、崩解剂、粘合剂、润滑剂及包衣剂；并且巴洛沙韦酯片采用环糊精包合技术，经过喷雾干燥制粒后，外加填充剂、崩解剂与润滑剂总混，最后压制成片剂。本发明制备的巴洛沙韦酯片溶出速率明显加快，提高了生物利用度，同时制备工艺稳定可控，产品质量稳定性好，用药安全性高，且便于服用、运输和储存，利于工业化生产。

USPTO Abstract

本申请涉及于药物制剂技术领域，尤其涉及一种巴洛沙韦酯片及其制备方法，提供了一种巴洛沙韦酯片，其组成为巴洛沙韦酯、包合剂、填充剂、崩解剂、粘合剂、润滑剂及包衣剂；并且巴洛沙韦酯片采用环糊精包合技术，经过喷雾干燥制粒后，外加填充剂、崩解剂与润滑剂总混，最后压制成片剂。本发明制备的巴洛沙韦酯片溶出速率明显加快，提高了生物利用度，同时制备工艺稳定可控，产品质量稳定性好，用药安全性高，且便于服用、运输和储存，利于工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN114306261A
Jurisdiction
CN
Classification
—
Expires
2022-04-12
Drug substance claim
No
Drug product claim
No
Assignee
Aomei Pharmaceutical Hainan Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.